These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

248 related articles for article (PubMed ID: 11769493)

  • 1. [Pleiotrophic effect of anti-hyperlipemic agents].
    Morishita R
    Nihon Naika Gakkai Zasshi; 2001 Oct; 90(10):2017-22. PubMed ID: 11769493
    [No Abstract]   [Full Text] [Related]  

  • 2. [Treatment of high blood cholesterol in patients with coronary heart disease].
    Nagai Y; Yamashita S
    Nihon Rinsho; 2003 Apr; 61 Suppl 4():675-81. PubMed ID: 12735049
    [No Abstract]   [Full Text] [Related]  

  • 3. Fenofibrate profiled as the fibrate with additional new data, supporting its use with statins in the European Medicines Agency recommendations.
    Cardiovasc J Afr; 2011; 22(1):55. PubMed ID: 21298212
    [No Abstract]   [Full Text] [Related]  

  • 4. [Fenofibrate].
    Yamashita T; Nakamura H
    Nihon Rinsho; 2001 Mar; 59 Suppl 3():618-24. PubMed ID: 11347142
    [No Abstract]   [Full Text] [Related]  

  • 5. [HMG-CoA reductase inhibitors (statin)].
    Yamamura T; Ishigami M
    Nihon Rinsho; 2007 Jul; 65 Suppl 7():458-64. PubMed ID: 17824071
    [No Abstract]   [Full Text] [Related]  

  • 6. Statins and the assessment of endothelial function.
    Lee KW; Felmeden DC; Lip GY
    J Intern Med; 2002 May; 251(5):452-3; author reply 453-4. PubMed ID: 11982746
    [No Abstract]   [Full Text] [Related]  

  • 7. Retinopathy progression in type 2 diabetes.
    Baum SJ
    N Engl J Med; 2010 Nov; 363(22):2172; author reply 2173-4. PubMed ID: 21105808
    [No Abstract]   [Full Text] [Related]  

  • 8. [Statins].
    Kobayashi J
    Nihon Rinsho; 2006 Dec; 64 Suppl 9():618-21. PubMed ID: 17458292
    [No Abstract]   [Full Text] [Related]  

  • 9. Effects of gemfibrozil conversion to fenofibrate on lipids in patients on statin therapy.
    Corbelli JC; Bullano MF; Willey VJ; Cziraky MJ; Corbelli ME; Waugh W
    Am J Cardiol; 2002 Dec; 90(12):1388-91. PubMed ID: 12480052
    [No Abstract]   [Full Text] [Related]  

  • 10. Fenofibrate and diabetic retinopathy.
    Firth J
    Lancet; 2008 Mar; 371(9614):722; author reply 722. PubMed ID: 18313496
    [No Abstract]   [Full Text] [Related]  

  • 11. Triglyceride levels, pancreatitis and choice of lipid-modifying therapy.
    Preiss D
    Expert Rev Gastroenterol Hepatol; 2013 Mar; 7(3):193-5. PubMed ID: 23445227
    [No Abstract]   [Full Text] [Related]  

  • 12. Focus on fenofibrate.
    Brown WV
    Hosp Pract (Off Ed); 1988 Jun; 23 Suppl 1():31-40. PubMed ID: 3134383
    [No Abstract]   [Full Text] [Related]  

  • 13. Combination of fenofibrate with non-statin drug regimens.
    Agouridis AP; Filippatos TD; Derdemezis CS; Mikhailidis DP; Elisaf MS
    Curr Pharm Des; 2010 Oct; 16(30):3401-16. PubMed ID: 20819059
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Fibrates and homocysteine.
    Young IS; Woodside JV
    Nutrition; 2001; 17(11-12):973-4. PubMed ID: 11744353
    [No Abstract]   [Full Text] [Related]  

  • 15. [Drug combination therapies for patients with hyperlipidemia and its significance].
    Onuma T; Kawamori R
    Nihon Rinsho; 2001 Mar; 59 Suppl 3():566-71. PubMed ID: 11347133
    [No Abstract]   [Full Text] [Related]  

  • 16. Does fenofibrate lower blood pressure?
    Koh KK
    Hypertension; 2013 Mar; 61(3):e27. PubMed ID: 23357183
    [No Abstract]   [Full Text] [Related]  

  • 17. Fenofibrate in the treatment of dyslipidemia associated with HIV infection.
    Samineni D; Fichtenbaum CJ
    Expert Opin Drug Metab Toxicol; 2010 Aug; 6(8):995-1004. PubMed ID: 20604734
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Treatment of hyperlipidaemia with fenofibrate and related fibrates.
    Filippatos T; Milionis HJ
    Expert Opin Investig Drugs; 2008 Oct; 17(10):1599-614. PubMed ID: 18808320
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Stimulation of bone formation by anti-hyperlipidemic agent statins and its mechanism of action].
    Yoneda T
    Nihon Rinsho; 2002 Mar; 60 Suppl 3():688-95. PubMed ID: 11979970
    [No Abstract]   [Full Text] [Related]  

  • 20. [Should the treatment of diabetic dyslipidemia be modified after the Action to Control Cardiovascular Risk in Diabetes Lipid study?].
    Pérez A
    Endocrinol Nutr; 2010 Dec; 57(10):457-9. PubMed ID: 20688585
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 13.